IDEAYA Biosciences
IDYA
209 hedge funds and large institutions have $2.91B invested in IDEAYA Biosciences in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 108 increasing their positions, 45 reducing their positions, and 24 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 45
123% more call options, than puts
Call options by funds: $1.86M | Put options by funds: $836K
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
42% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 24
5% more funds holding
Funds holding: 199 → 209 (+10)
0% more capital invested
Capital invested by funds: $2.9B → $2.91B (+$14.1M)
0.23% less ownership
Funds ownership: 108.99% → 108.77% (-0.23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$51.8M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$51.1M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$41.2M |
| 4 |
BlackRock
New York
|
+$33.1M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$24.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$49.6M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$41.1M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$27.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$16.2M |
| 5 |
Morgan Stanley
New York
|
-$16.1M |
IDYA Hedge Fund Activity: Q3 2024 in Review
209 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q3 2024, worth a combined $2.91B — up 0.49% from $2.9B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new IDYA positions and 24 closed out — a net gain of 10 holders — while 108 added to existing stakes and 45 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $51.8M. The largest seller was Holocene Advisors, cutting an estimated $49.6M.
- 209 institutional investors held IDEAYA Biosciences (IDYA) as of Q3 2024, up from 199 in Q2 2024.
- Funds reported $2.91B of IDEAYA Biosciences stock for Q3 2024, up 0.49% quarter-over-quarter.
- 34 funds opened new IDEAYA Biosciences positions in Q3 2024 and 24 closed out, a net change of +10 holders.
- The largest IDEAYA Biosciences buyer in Q3 2024 was Fidelity Investments, an estimated $51.8M added.
- The largest IDEAYA Biosciences seller in Q3 2024 was Holocene Advisors, an estimated $49.6M sold.
Based on aggregated 13F filings for Q3 2024.